Leonteq Securities’s Fusion Pharmaceuticals FUSN Stock Holding History
Bought
Maintained
Sold
Other funds holding FUSN
Leonteq Securities's FUSN Position: Q4 2023 in Review
Leonteq Securities sold out of Fusion Pharmaceuticals (FUSN) in Q4 2023, closing a stake of 35,000 shares — an estimated $91K sold.
Leonteq Securities first reported a position in FUSN in Q4 2022 and held it in 4 quarters. The position peaked at $167K in Q4 2022. 77 funds tracked by Wall St. Rank hold FUSN as of Q4 2023.
- Leonteq Securities reported no remaining Fusion Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
- Leonteq Securities sold 35,000 Fusion Pharmaceuticals shares in Q4 2023, an estimated $91K.
- Leonteq Securities first reported a position in Fusion Pharmaceuticals in Q4 2022 and held it in 4 quarters.
- Leonteq Securities's Fusion Pharmaceuticals position peaked at $167K in Q4 2022.
- 77 funds tracked by Wall St. Rank held Fusion Pharmaceuticals as of Q4 2023.
Based on Leonteq Securities's 13F filing for Q4 2023, filed 11 Mar 2026.